Staff Profile

James O’Hara is an Ear Nose and Throat consultant, with a specialist interest in head and neck cancer. He is a co-applicant on four NIHR funded clinical randomised-controlled trials; exploring chronic throat symptoms, adult tonsillitis, nasal surgery and laser therapy during head and neck radiotherapy. 

Area of expertise

Ear, Nose and Throat Conditions
Head and Neck Cancer
Clinical Trials

• Schache A, Kerawala C, Ahmed O, Brennan PA, Cook F, Garrett M, Homer J, Hughes C, Mayland C, Mihai R, Newbold K, O'Hara J, Roe J, Sibtain A, Smith M, Thavaraj S, Weller A, Winter L, Young V, Winter SC. British Association of Head and Neck Oncologists (BAHNO) standards 2020. Journal of Oral Pathology and Medicine 2021, 50(3), 262-273.
• Bradish T, Fisher H, Paleri V, Robinson M, Meikle D, Kelly C, O'Hara J. How applicable is the TNM 8 staging for human papillomavirus (HPV) related oropharyngeal squamous cell carcinoma (OPSCC) to a UK population of 106 patients?: A cohort comparison of the TNM 7 and TNM8 staging systems for HPV positive oropharyngeal cancer in a UK population. European Archives of Oto-Rhino-Laryngology 2021, 278, 755-761.
• Wilson JA, Stocken DD, Watson GC, Fouweather T, McGlashan J, MacKenzie K, Carding P, Karagama Y, Harries M, Ball S, Khwaja S, Costello D, Wood R, Lecouturier J, O'Hara J. Lansoprazole for persistent throat symptoms in secondary care: the TOPPITS RCT. Health Technology Assessment 2021, 25(3), 1-118.
• O'Hara J, Warner L, Fox H, Hamilton D, Meikle D, Counter P, Robson A, Goranova R, Iqbal S, Kelly C, Robinson M, Paleri V. Primary transoral robotic surgery +/- adjuvant therapy for oropharyngeal squamous cell carcinoma—A large observational single-centre series from the United Kingdom. Clinical Otolaryngology 2021, 46(5), 1005-1012.
• Rajgor A, Patel A, McCulloch D, Obara B, Bacardit J, McQueen A, Aboagye E, Ali T, O'Hara J, Hamilton D. The application of radiomics in laryngeal cancer. British Journal of Radiology 2021, 94(1128), 20210499.
• Lin DJ, Ng JCK, Huang L, Robinson M, O'Hara J, Wilson JA, Mellor AL. The immunotherapeutic role of indoleamine 2,3-dioxygenase in head and neck squamous cell carcinoma: A systematic review. Clinical Otolaryngology 2021, 46(5), 919-934.
• O'Hara J, Stocken DD, Watson GC, Fouweather T, McGlashan J, MacKenzie K, Carding P, Karagama Y, Wood R, Wilson JA. Use of proton pump inhibitors to treat persistent throat symptoms: multicentre, double blind, randomised, placebo controlled trial. British Medical Journal 2021, 372, m4903.
• Fox HR, Robson A, Cocks H, Meikle D, Kelly C, Goranova R, Kovarik J, Shaikh G, Paleri V, O'Hara J. Contralateral neck metastases in lateralised, resectable advanced stage oropharyngeal squamous cell carcinoma—Results of 57 patients undergoing bilateral selective neck dissection. Clinical Otolaryngology 2018, 43(2), 739-741.
• Siddiq S, Cartlidge D, Stephen S, Sathasivam HP, Fox H, O'Hara J, Meikle D, Iqbal MS, Kelly CG, Robinson M, Paleri V. Robotic lateral oropharyngectomy following diagnostic tonsillectomy is oncologically safe in patients with high risk human papillomavirus related squamous cell cancer. European Archives of Oto-Rhino-Laryngology 2018, 275(7), 1853-1860.
• Paleri V, Fox H, Coward S, Ragbir M, Mcqueen A, Ahmed O, Meikle D, Saleh D, O'Hara J, Robinson M. Transoral robotic surgery for residual and recurrent oropharyngeal cancers: Exploratory study of surgical innovation using the IDEAL framework for early-phase surgical studies. Head and Neck 2018, 40(3), 512-525.
• Owen S, Puvanendran M, Meikle D, Bowe I, O'Hara J, Patterson J, Paleri V. Baseline swallowing measures predict recovery at 6 weeks after transoral robotic surgery for head and neck cancer. Clinical Otolaryngology 2017, 42(2), 366-372.
• Powell J, O'Hara J, Carrie S, Wilson JA. Is tonsillectomy recommended in adults with recurrent acute tonsillitis?. BMJ 2017, 357, j1450.
• McSweeney LA, O'Hara JT, Rousseau NS, Stocken DD, Sullivan F, Vale L, Wilkes S, Wilson JA, Haighton CA. ‘Thinking that somebody's going to delay [a tonsillectomy] for one to two years is quite horrifying really’: a qualitative feasibility study for the NAtional Trial of Tonsillectomy IN Adults (NATTINA Part 2). Clinical Otolaryngology 2016, 42(3), 578-583.
• Dawe N, Patterson J, OHara J. Functional swallowing outcomes following treatment for oropharyngeal carcinoma: A systematic review of the evidence comparing trans-oral surgery versus non-surgical management. Clinical Otolaryngology 2016, 41(4), 371-385.
• O'Hara J, Goff D, Cocks H, Moor J, Hartley C, Muirhead C, Patterson JM. One-year swallowing outcomes following Transoral Laser Microsurgery +/- Adjuvant Therapy versus Primary Chemoradiotherapy for Advanced Stage Oropharyngeal Squamous Cell Carcinoma. Clinical Otolaryngology 2016, 41(2), 169-175.
• Watson G, O'Hara J, Carding P, Lecouturier J, Stocken D, Fouweather T, Wilson JA. TOPPITS: Trial Of Proton Pump Inhibitors in Throat Symptoms. Study protocol for a randomised controlled trial. BMC Trials 2016, 17, 175.
• Rubie IEM, Haighton CA, O'Hara J, Rousseau NS, Steen IN, Stocken DD, Sullivan F, Vale L, Wilkes S, Wilson JA. The NAtional randomised controlled Trial of Tonsillectomy IN Adults (NATTINA): a clinical and cost-effectiveness study: study protocol for a randomised control trial. BMC Trials 2015, 16(1), 263.
• O'Hara J, Cosway B, Muirhead C, Leonard N, Goff D, Patterson JM. Transoral laser microsurgery +/- adjuvant therapy versus chemoradiotherapy for stage III and IVA oropharyngeal squamous cell carcinoma: Preliminary comparison of early swallowing outcomes. Head & Neck 2015, 37(10), 1488-1494.
• Powell J, O'Hara J, Wilson J. Are persistent throat symptoms atypical features of gastric reflux and should they be treated with proton pump inhibitors. BMJ 2014, 349, g5813.